• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Career Development

Tranexamic acid reduces life-threatening postpartum bleeding

byNeel MistryandTeddy Guo
December 10, 2024
in Career Development, Emergency, ENT, Obstetrics, Pharma
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Tranexamic acid significantly reduced life-threatening postpartum bleeding.

2. There were no differences in the risk of thromboembolic events.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Postpartum hemorrhage is a significant cause of maternal mortality. While tranexamic acid is used to treat this condition, its potential to prevent bleeding remains unclear. This systematic review and meta-analysis aimed to examine tranexamic acid’s effects in reducing life-threatening bleeding and thromboembolic risk in women giving birth. The primary outcome of this study was the number of women with life-threatening bleeding, while a key secondary outcome was the incidence of thromboembolic events. According to study results, tranexamic acid significantly lowered the risk of life-threatening bleeding compared to placebo. Although this study was well done, it was limited by its focus on a specific subset of large, low-bias trials, which may not fully represent outcomes in broader populations.

Click to read the study in The Lancet

Relevant Reading: Tranexamic Acid in Patients Undergoing Noncardiac Surgery

RELATED REPORTS

Pre-conception computed tomography ionizing radiation may be associated with worse reproductive outcomes

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

Fetal cerebrovascular response to maternal hyperoxia testing may help predict neurodevelopmental outcomes

In-depth [systematic review and meta-analysis]: Randomized trials assessing the effects of tranexamic acid in women giving birth were assessed from databased inception to Aug 4, 2024. Included were those that were prospectively registered, placebo-controlled, involving > 500 patients, and having low bias risk. Altogether, 54 404 women were included in the final analysis. The primary outcome showed that tranexamic acid significantly reduced the rate of life-threatening postpartum bleeding compared to placebo (178 vs. 230, odds ratio [OR] 0.77, 95% confidence interval [CI] 0.63-0.93, p=0.008). The secondary outcome of thromboembolic events found no significant difference between groups (50 vs. 52, OR 0.96, 95% CI 0.65-1.41, p=0.82). Findings from this study suggest that tranexamic acid is effective in preventing severe bleeding in childbirth without increasing thromboembolic risks.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: obstetricspostpartum bleedingpostpartum hemorrhagepregnancyTranexamic acidTXA
Previous Post

Invasive treatment not superior to medical therapy in older adults with NSTEMI

Next Post

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

RelatedReports

Half of parents aware of CT radiation cancer risk
Obstetrics

Pre-conception computed tomography ionizing radiation may be associated with worse reproductive outcomes

September 8, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

August 22, 2025
Neurology

Fetal cerebrovascular response to maternal hyperoxia testing may help predict neurodevelopmental outcomes

July 23, 2025
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Weekly Rewinds

2 Minute Medicine Rewind July 21, 2025

July 21, 2025
Next Post
USPSTF recommends chemoprevention for women at high risk for breast cancer

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

Maternal cell-free DNA sequencing superior to standard aneuploidy screening [CARE Study]

Australian couple-based genetic screening program feasible and accepted

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Acupuncture for Chronic Low Back Pain in Older Adults: A Randomized Clinical Trial
  • Spironolactone does not reduce cardiovascular events in patients receiving maintenance dialysis
  • What Is the Cricothyroid Membrane and Why It Matters in Medicine
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.